The Non-Malignant Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2023 | The importance of proactive hemophilia carrier screening: gender equity in hemophilia care
Hemophilia is an X-linked recessive bleeding disorder which is classically thought to affect males, and often, female carriers go undiagnosed. In this video, Evelien Krumb, MD, UCLouvain Saint-Luc, Brussels, Belgium, shares insights into a proactive hemophilia carrier screening project which aimed to identify and screen female carriers of hemophilia A and B using genetic testing and retrospective data. Results demonstrated a significant difference in coagulation factor levels in carriers versus non-carriers, and this study emphasizes the importance of incorporating proactive and systematic screening in clinical practice. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Research Funding: Swedish Orphan Biovitrum (Sobi), CSL Behring
Honoraria: BioMarin
